Remus Pharmaceuticals (NSE:REMUS) Change In Receivables : ₹59 Mil (TTM As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Remus Pharmaceuticals Change In Receivables?

Remus Pharmaceuticals's change in receivables for the quarter that ended in Sep. 2024 was ₹501 Mil. It means Remus Pharmaceuticals's Accounts Receivable declined by ₹501 Mil from Mar. 2024 to Sep. 2024 .

Remus Pharmaceuticals's change in receivables for the fiscal year that ended in Mar. 2024 was ₹-565 Mil. It means Remus Pharmaceuticals's Accounts Receivable increased by ₹565 Mil from Mar. 2022 to Mar. 2024 .

Remus Pharmaceuticals's Accounts Receivable for the quarter that ended in Sep. 2024 was ₹597 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Remus Pharmaceuticals's Days Sales Outstanding for the six months ended in Sep. 2024 was 39.94.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Remus Pharmaceuticals's liquidation value for the six months ended in Sep. 2024 was ₹111 Mil.

Remus Pharmaceuticals Change In Receivables Historical Data

The historical data trend for Remus Pharmaceuticals's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remus Pharmaceuticals Change In Receivables Chart

Remus Pharmaceuticals Annual Data

Trend

Mar20

Mar21

Mar22

Mar24

Change In Receivables

-7.81

-23.92

5.63

-564.78

Remus Pharmaceuticals Semi-Annual Data
	Mar20	Mar21	Mar22	Sep23	Mar24	Sep24
Change In Receivables	Get a 7-Day Free Trial			-	-	-123.47	-441.31	500.52

Remus Pharmaceuticals Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹59 Mil.

Remus Pharmaceuticals (NSE:REMUS) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Remus Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	596.76	/	2726.845	*	91
=	39.94

2. In Ben Graham's calculation of liquidation value, Remus Pharmaceuticals's accounts receivable are only considered to be worth 75% of book value:

Remus Pharmaceuticals's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	459.929	-	985.396	+	0.75 * 596.76	+	0.5 * 378.582
=	111

Remus Pharmaceuticals Change In Receivables Related Terms

Thank you for viewing the detailed overview of Remus Pharmaceuticals's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Remus Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Remus Pharmaceuticals Ltd (NSE:REMUS) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ambli bopal Road, 1101 to 1103, South Tower, One 42, Behind Ashok Vatika, Near Jayantilal Park BRTS, Ahmedabad, GJ, IND, 380054

Website

https://www.remuspharma.com

Remus Pharmaceuticals Ltd is engaged in the marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). It also provides technical consultancy services to various distributors for the preparation of reports on the dossiers of the products to be registered by them in various countries. Remus Pharmaceuticals market niche medicinal combinations. It exports generic drugs by conducting intensive market research in the pharmaceutical industry to expand its product portfolio.

Remus Pharmaceuticals Headlines

No Headlines